Codiak BioSciences, Inc.
NASDAQ:CDAK
Income Statement
Earnings Waterfall
Codiak BioSciences, Inc.
Revenue
|
34.1m
USD
|
Operating Expenses
|
-82.9m
USD
|
Operating Income
|
-48.8m
USD
|
Other Expenses
|
31.4m
USD
|
Net Income
|
-17.4m
USD
|
Income Statement
Codiak BioSciences, Inc.
Sep-2019 | Dec-2019 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
0
N/A
|
0
+63%
|
1
+59%
|
1
+129%
|
3
+105%
|
16
+453%
|
17
+4%
|
17
+1%
|
23
+36%
|
22
-2%
|
35
+55%
|
34
-2%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(59)
|
(81)
|
(82)
|
(97)
|
(94)
|
(117)
|
(101)
|
(87)
|
(92)
|
(57)
|
(55)
|
(83)
|
|
Selling, General & Administrative |
(17)
|
(21)
|
(18)
|
(18)
|
(20)
|
(26)
|
(25)
|
(27)
|
(28)
|
(28)
|
(28)
|
(28)
|
|
Research & Development |
(42)
|
(60)
|
(64)
|
(78)
|
(74)
|
(91)
|
(76)
|
(61)
|
(65)
|
(63)
|
(60)
|
(55)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
33
|
0
|
|
Operating Income |
(58)
N/A
|
(80)
-37%
|
(81)
-1%
|
(95)
-17%
|
(91)
+4%
|
(101)
-11%
|
(84)
+17%
|
(71)
+16%
|
(70)
+1%
|
(35)
+50%
|
(20)
+42%
|
(49)
-143%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
1
|
1
|
0
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
0
|
0
|
29
|
|
Total Other Income |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
|
Pre-Tax Income |
(56)
N/A
|
(78)
-38%
|
(81)
-4%
|
(95)
-18%
|
(92)
+4%
|
(102)
-11%
|
(85)
+16%
|
(72)
+16%
|
(37)
+48%
|
(35)
+6%
|
(20)
+43%
|
(17)
+12%
|
|
Net Income | |||||||||||||
Income from Continuing Operations |
(56)
|
(78)
|
(81)
|
(95)
|
(92)
|
(102)
|
(85)
|
(72)
|
(37)
|
(35)
|
(20)
|
(17)
|
|
Net Income (Common) |
(56)
N/A
|
(78)
-38%
|
(81)
-4%
|
(95)
-18%
|
(92)
+4%
|
(102)
-11%
|
(85)
+16%
|
(72)
+16%
|
(37)
+48%
|
(35)
+6%
|
(20)
+43%
|
(17)
+12%
|
|
EPS (Diluted) |
-0.58
N/A
|
-0.79
-36%
|
-0.83
-5%
|
-0.98
-18%
|
-0.94
+4%
|
-5.02
-434%
|
-3.86
+23%
|
-3.22
+17%
|
-1.66
+48%
|
-1.55
+7%
|
-0.88
+43%
|
-0.69
+22%
|